Update: Temple Health and Keystone First Family Health Plans have reached a new contract agreement. 

Learn More
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON)

view all Clinical Trials

Overview

Study designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with idiopathic pulmonary fibrosis (IPF).

Clinical Trial Information

Protocol

TIRB# 28715

Phase

3

Condition(s)

Interstitial Lung Disease (ILD), Idiopathic Pulmonary Fibrosis (IPF), Pulmonary Fibrosis (Including IPF)

Investigator

Parth Rali, MD

Coordinator

Kim Selwood

Visit clinicaltrials.gov for full description.

Contact

For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.

Full Title

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis